The current issue of JAMA Internal Medicine (2024)

Health Care Policy and Law

Primary Care’s Role in Prescribing Mail-Order Mifepristone

Emily M.Godfrey,MD, MPH; YingZhang,MD, MPH; Debra B.Stulberg,MD, MA

has audio

JAMA Intern Med. 2024;184(8):859-860. doi:10.1001/jamainternmed.2024.1448

This Viewpoint discusses the controversy over mail-order mifepristone prescribed by primary care clinicians for first-trimester abortion as it relates to the history of initial approval, the Supreme Court case Alliance for Hippocratic Medicine v US Food and Drug Administration, and available clinical research.

• Audio: Mail-Order Pharmacy Dispensing of Mifepristone for Abortion After In-Person Screening

Women's Health

Protecting Sexual and Reproductive Health Privacy Post-Dobbs

ElizabethTobin-Tyler,JD, MA; EliAdashi,MD, MS

JAMA Intern Med. 2024;184(8):861-862. doi:10.1001/jamainternmed.2024.1652

This Viewpoint discusses the dangers to abortion providers and patients of law enforcement access to sexual and reproductive health information.

How Should Medicare Pay for Artificial Intelligence?

AnnaZink,PhD; Michael E.Chernew,PhD; Hannah T.Neprash,PhD

JAMA Intern Med. 2024;184(8):863-864. doi:10.1001/jamainternmed.2024.1648

This Viewpoint examines artificial intelligence–enabled clinical services, existing payment structures, and the economics of artificial intelligence pricing.

Less Care at Higher Cost—The Medicare Advantage Paradox

AdamGaffney,MD, MPH; StephanieWoolhandler,MD, MPH; David U.Himmelstein,MD

JAMA Intern Med. 2024;184(8):865-866. doi:10.1001/jamainternmed.2024.1868

This Viewpoint makes the case for eliminating Medicare Advantage and doubling down on Traditional Medicare.

Integration of Primary and Oral Health Care—An Unrealized Opportunity

LisaSimon,MD, DMD; IraLamster,DDS, MMSc

JAMA Intern Med. 2024;184(8):869-870. doi:10.1001/jamainternmed.2024.2267

This Viewpoint discusses how dentists could provide some primary health care services as part of an interdisciplinary team, easing the burden on clinicians.

Turn a Kind Eye—Offering Positive Reframing

Eleanor R.Menzin,MD

JAMA Intern Med. 2024;184(8):871. doi:10.1001/jamainternmed.2024.2379

This essay describes the importance of physicians using positive reframing with patients.

Women's Health

Mail-Order Pharmacy Dispensing of Mifepristone for Medication Abortion After In-Person Screening

DanielGrossman,MD; SarahRaifman,MSc; NatalieMorris,MPH; et al.

open access has audio

JAMA Intern Med. 2024;184(8):873-881. doi:10.1001/jamainternmed.2024.1476

This cohort study estimates the effectiveness, acceptability, and feasibility of dispensing mifepristone for medication abortion using a mail-order pharmacy.

• Audio: Mail-Order Pharmacy Dispensing of Mifepristone for Abortion After In-Person Screening

Lung Cancer Screening in the US, 2022

PritiBandi,PhD; JessicaStar,MA, MPH; KilanAshad-Bishop,PhD; et al.

has audio

JAMA Intern Med. 2024;184(8):882-891. doi:10.1001/jamainternmed.2024.1655

This cross-sectional study investigates the prevalence of up-to-date lung cancer screening across the 50 US states and the District of Columbia in 2022.

• Audio: Lung Cancer Screening in the US, 2022

Patient Navigation for Lung Cancer Screening at a Health Care for the Homeless Program: A Randomized Clinical Trial

Travis P.Baggett,MD, MPH; NoraSp*rn,MA, MPH; JoanaBarbosa Teixeira,MA; et al.

JAMA Intern Med. 2024;184(8):892-902. doi:10.1001/jamainternmed.2024.1662

This randomized clinical trial examines whether patient navigation improves lung cancer screening completion among people experiencing homelessness.

Early-Life Circ*mstances and Racial Disparities in Cognition Among Older Adults in the US

ZhuoerLin,PhD; JustinYe,BA; HeatherAllore,PhD; et al.

JAMA Intern Med. 2024;184(8):904-914. doi:10.1001/jamainternmed.2024.1132

This cross-sectional study assesses how racial differences in early life, particularly educational circ*mstances, are collectively and individually associated with racial disparities in late-life cognition among older adults in the US.

• Editorial

  Early-Life Education Quality and Quantity

  Raegan W.Durant,MD, MPH

  JAMA Intern Med

Electronic Cigarettes vs Varenicline for Smoking Cessation in Adults: A Randomized Clinical Trial

AnnaTuisku,PhD; MikkoRahkola,MD; PenttiNieminen,PhD; et al.

JAMA Intern Med. 2024;184(8):915-921. doi:10.1001/jamainternmed.2024.1822

This randomized clinical trial examines the relative effectiveness of electronic cigarettes in smoking cessation.

Cytisinicline for Vaping Cessation in Adults Using Nicotine E-Cigarettes: The ORCA-V1 Randomized Clinical Trial

Nancy A.Rigotti,MD; Neal L.Benowitz,MD; Judith J.Prochaska,PhD, MPH; et al.

open access

JAMA Intern Med. 2024;184(8):922-930. doi:10.1001/jamainternmed.2024.1313

This randomized clinical trial seeks to determine the efficacy and safety of cytisinicline vs placebo to produce abstinence from e-cigarette use in adults seeking to quit vaping nicotine.

Estimated Effectiveness of the BNT162b2 XBB Vaccine Against COVID-19

Sara Y.Tartof,PhD, MPH; Jeff M.Slezak,MS; Timothy B.Frankland,MA; et al.

open access

JAMA Intern Med. 2024;184(8):932-940. doi:10.1001/jamainternmed.2024.1640

This case-control study estimates the association between receipt of the BNT162b2 XBB vaccine and medically attended COVID-19 outcomes among US adults 18 years and older.

Severe Acute Liver Injury After Hepatotoxic Medication Initiation in Real-World Data

JessieTorgersen,MD, MHS, MSCE; Alyssa K.Mezochow,MD; Craig W.Newcomb,MS; et al.

open access

JAMA Intern Med. 2024;184(8):943-952. doi:10.1001/jamainternmed.2024.1836

This cohort study identifies the most potentially hepatotoxic medications based on clinical incidence rates of hospitalizations for severe acute liver injury (ALI) and examines how these rates compare with the hepatotoxicity categorization of severe ALI using published case reports.

Overdose, Behavioral Health Services, and Medications for Opioid Use Disorder After a Nonfatal Overdose

Christopher M.Jones,PharmD, DrPH; CarlaShoff,PhD; CarlosBlanco,MD, PhD; et al.

JAMA Intern Med. 2024;184(8):954-962. doi:10.1001/jamainternmed.2024.1733

This cohort study evaluates access to medications for opioid use disorder (MOUD), naloxone, and behavioral health care and their association with decreased fatal overdose risk among Medicare beneficiaries with recent nonfatal overdose experience.

Atherosclerotic Cardiovascular Disease Risk Estimates Using the Predicting Risk of Cardiovascular Disease Events Equations

Timothy S.Anderson,MD, MAS; Linnea M.Wilson,MPH; Jeremy B.Sussman,MD, MS

JAMA Intern Med. 2024;184(8):963-970. doi:10.1001/jamainternmed.2024.1302

This cross-sectional study compares 10-year atherosclerotic cardiovascular disease risk and recommendations for primary prevention statin therapy between the 2023 American Heart Association (AHA) Predicting Risk of Cardiovascular Disease (CVD) Events (PREVENT) equations and the 2013 AHA/American College of Cardiology pooled cohort equations.

Early-Life Education Quality and Quantity

Raegan W.Durant,MD, MPH

JAMA Intern Med. 2024;184(8):872. doi:10.1001/jamainternmed.2024.1141

Health Care Reform

The Case for Continuing to Improve Medicare Advantage: Misplaced Nostalgia for Traditional Medicare

Sachin H.Jain,MD, MBA

JAMA Intern Med. 2024;184(8):867-869. doi:10.1001/jamainternmed.2024.1865

Progress in Lung Cancer Screening Adoption

Ilana B.Richman,MD, MHS; Cary P.Gross,MD

has audio

JAMA Intern Med. 2024;184(8):902-903. doi:10.1001/jamainternmed.2024.1673

• Audio: Lung Cancer Screening in the US, 2022

Time for a Focus on Cessation of E-Cigarettes

SuchitraKrishnan-Sarin,PhD; Lisa M.Fucito,PhD

JAMA Intern Med. 2024;184(8):930-931. doi:10.1001/jamainternmed.2024.1310

Evaluating COVID-19 Vaccines in the Era of Endemicity—Recency vs Reformulation

Gopi S.Mohan,MD, PhD; Michael J.Mina,MD, PhD; Pierre O.Ankomah,MD, PhD

JAMA Intern Med. 2024;184(8):940-942. doi:10.1001/jamainternmed.2024.1637

Rethinking Drug-Induced Liver Injury—A New Era of Pharmacovigilance

Grace Y.Zhang,MD; Jessica B.Rubin,MD, MPH

JAMA Intern Med. 2024;184(8):952-953. doi:10.1001/jamainternmed.2024.1833

Prioritizing Women’s Inclusion in Clinical Trials of Medical Devices

Jessica N.Holtzman,MD; Rita F.Redberg,MD, MSc

JAMA Intern Med. 2024;184(8):979-980. doi:10.1001/jamainternmed.2024.1844

Harnessing Social Needs Data to Advance Health Equity in Federally Qualified Health Centers

MathiasLalika,MD, MPH; GbengaOgedegbe,MD, MPH; LaPrincess C.Brewer,MD, MPH

JAMA Intern Med. 2024;184(8):982-984. doi:10.1001/jamainternmed.2024.1871

Association of Political Assaults With the Health of Transgender and Nonbinary Persons

Carl G.StreedJr,MD, MPH; Kellan E.Baker,PhD, MPH, MA; Arjee JavellanaRestar,PhD, MPH

JAMA Intern Med. 2024;184(8):986-987. doi:10.1001/jamainternmed.2024.2553

Women's Health

Women’s Representation in RCTs Evaluating FDA-Supervised Medical Devices: A Systematic Review

Nitzan KarnyEpstein,MD; MayaHarpaz,MD; MohamadAbo-Molhem,MD; et al.

JAMA Intern Med. 2024;184(8):977-979. doi:10.1001/jamainternmed.2024.1011

This systematic review evaluates the representation of women in randomized clinical trials (RCTs) of US Food and Drug Administration (FDA)–supervised medical devices.

National Prevalence of Social Risk Factors at Federally Qualified Health Centers

Kevin H.Nguyen,PhD; Nicole C.Giron,MS; Megan B.Cole,PhD, MPH

JAMA Intern Med. 2024;184(8):980-982. doi:10.1001/jamainternmed.2024.1881

This cross-sectional study estimates positive screening rates for 4 social risk factors and assesses federally qualified health center characteristics associated with higher positive screening rates.

Health and the 2024 US Election

Health Status and Mental Health of Transgender and Gender-Diverse Adults

MichaelLiu,MPhil; Vishal R.Patel,MD, MPH; Sari L.Reisner,ScD; et al.

JAMA Intern Med. 2024;184(8):984-986. doi:10.1001/jamainternmed.2024.2544

This cross-sectional study examines self-reported poor or fair health status, frequent mental distress, and depression among transgender and gender-diverse respondents compared with cisgender respondents to the 2014 to 2022 Behavioral Risk Factor Surveillance System.

Health Care Policy and Law

Racial and Ethnic Disparities in Medicaid Disenrollment After the End of the COVID-19 Public Health Emergency

Kranti C.Rumalla,BA; Daniel B.Nelson,MD, MPP; K. JohnMcConnell,PhD; et al.

JAMA Intern Med. 2024;184(8):987-989. doi:10.1001/jamainternmed.2024.1503

This survey study reports the proportions of and reasons for Medicaid coverage loss among racially and ethnically minoritized individuals.

Recurrent Urinary Tract Infection in Older Outpatient Women

Alison J.Huang,MD, MAS; DeborahGrady,MD, MPH; LonaMody,MD, MSc

JAMA Intern Med. 2024;184(8):971-972. doi:10.1001/jamainternmed.2024.1069

This Clinical Insights discusses special considerations in recurrent urinary tract infection diagnosis and management in older women.

Increasing Risk for Tick-Borne Disease: What Should Clinicians Know?

Sam R.TelfordIII,ScD; Philip E.Stewart,PhD; Marshall E.Bloom,MD

JAMA Intern Med. 2024;184(8):973-974. doi:10.1001/jamainternmed.2024.1754

This clinical insights article examines reasons behind the increase in tick-borne diseases and what clinicians should know about diagnosis and mitigation.

An Unusual ST-Segment Elevation in Unexplained Syncope

GuangqiangWang,MS

free access has active quiz

JAMA Intern Med. 2024;184(8):975-976. doi:10.1001/jamainternmed.2024.1005

This case report describes a patient in their 70s with a lambda wave pattern on electrocardiography.

What Should I Know About Recurrent UTIs in Older Women?

Sonali D.Advani,MBBS, MPH; Kimberly C.Claeys,PharmD, PhD; Nazema Y.Siddiqui,MD, MHSc

free access

JAMA Intern Med. 2024;184(8):994. doi:10.1001/jamainternmed.2024.1854

This JAMA Internal Medicine Patient Page describes urinary tract infections, their causes, and how to treat them and prevent future episodes.

Physician Work Environment and Well-Being

Private Equity in Healthcare—Safeguarding Patient Care

Jason E.Liebowitz,MD

JAMA Intern Med. 2024;184(8):989. doi:10.1001/jamainternmed.2024.1887

• Editor's Note

  Physicians in Private Equity Practices—Canaries in a Coal Mine?

  Cary P.Gross,MD; GiselleCorbie,MD, MSc

  JAMA Intern Med

Challenges With Relying on Body Fat and Weight Values for Obesity

Henry S.Kahn,MD

JAMA Intern Med. 2024;184(8):989-990. doi:10.1001/jamainternmed.2024.2370

Challenges With Relying on Body Fat and Weight Values for Obesity

LuXiao,MD

JAMA Intern Med. 2024;184(8):990. doi:10.1001/jamainternmed.2024.2373

Challenges With Relying on Body Fat and Weight Values for Obesity—Reply

AdityaNarayan,BS; Ank A.Agarwal,BA; Fatima CodyStanford,MD, MPH, MPA, MBA

JAMA Intern Med. 2024;184(8):990-991. doi:10.1001/jamainternmed.2024.2376

Proactively Designing Generative Artificial Intelligence for Primary Care

DavidFraile-Navarro,MD, PhD; RichardLehman,MA, BM, BCh

JAMA Intern Med. 2024;184(8):991-992. doi:10.1001/jamainternmed.2024.2584

• Editorial

  The Perils of Artificial Intelligence in a Clinical Landscape

  IsabelOstrer,MD; LouiseAronson,MD, MFA

  JAMA Intern Med

Proactively Designing Generative Artificial Intelligence for Primary Care—Reply

UrmimalaSarkar,MD, MPH; David W.Bates,MD, MSc

JAMA Intern Med. 2024;184(8):992. doi:10.1001/jamainternmed.2024.2550

• Editorial

  The Perils of Artificial Intelligence in a Clinical Landscape

  IsabelOstrer,MD; LouiseAronson,MD, MFA

  JAMA Intern Med

Article Changed to Open Access

free access

JAMA Intern Med. 2024;184(8):992. doi:10.1001/jamainternmed.2024.2589

Typographical Errors in Table 2

free access

JAMA Intern Med. 2024;184(8):993. doi:10.1001/jamainternmed.2024.3009

Error in Figure 1

free access

JAMA Intern Med. 2024;184(8):993. doi:10.1001/jamainternmed.2024.3261

Error in the Table

free access

JAMA Intern Med. 2024;184(8):993. doi:10.1001/jamainternmed.2024.3784

Error in Visual Abstract

free access

JAMA Intern Med. 2024;184(8):993. doi:10.1001/jamainternmed.2024.3981

JAMA Internal Medicine

free access

JAMA Intern Med. 2024;184(8):858. doi:10.1001/jamainternmed.2023.5576